A New Approach to Cell Culture
The Advanced Therapy Bioreactor (ATB™) is ABEC’s closed, automated single-use platform designed to support sensitive, perfusion-driven advanced therapy processes. Engineered to deliver a high level of control and reproducibility, the ATB creates stable, well-defined culture conditions that enable confident scale-up and reliable performance to move cell and gene therapy programs forward—without unnecessary complexity.
PROVEN TO DELIVER
REPEATABLE PERFORMANCE
Advanced therapy manufacturing brings new challenges: sensitive cell lines, tight control windows, and increased risk of variability. ABEC’s ATB™ is purpose-built to address these challenges, applying proven engineering to support emerging cell and gene therapy workflows.
Delivering closed, automated operation with consistent, reproducible performance, ATB provides a clear path from early development through scalable manufacturing. Enabling more confident, consistent progress for advanced therapy manufacturing.
IDEAL CELL ENVIRONMENT
ABEC’s ATB™ is designed to protect sensitive cell cultures through controlled mixing, efficient gas transfer, and stable process conditions. With a closed, automated system, it delivers consistent, reproducible performance run after run.
FULLY CLOSED PROCESSING
The ATB™ features fully closed, automated workflows that minimize contamination risk, reduce operator variability, and limit manual intervention—delivering consistent performance in advanced therapy manufacturing environments.
SEAMLESS SCALABILITY
ATB™ provides a standardized, scalable platform from 0.2L to 10L, supporting R&D through commercial manufacturing. Designed for repeatability and scale-out, the ATB integrates seamlessly into broader facility strategies, including hybrid and stainless steel solutions.
FAST DEPLOYMENT
ATB is designed for efficient installation, validation, and operation—helping teams move from development into production readiness without any unnecessary delays or redesign.
BACKED BY A FULL ECOSYSTEM
ATB maximizes ABEC’s broader capabilities in process sciences, automation, Hybrid BioProcessing, and lifecycle services—ensuring performance is supported not just at installation, but as processes evolve. ATB isn’t a standalone solution—it’s part of a proven ecosystem.
